1-110603598-C-G
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004974.4(KCNA2):āc.1185G>Cā(p.Ala395Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0507 in 1,613,908 control chromosomes in the GnomAD database, including 2,532 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. A395A) has been classified as Likely benign.
Frequency
Consequence
NM_004974.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNA2 | NM_004974.4 | c.1185G>C | p.Ala395Ala | synonymous_variant | 3/3 | ENST00000316361.10 | NP_004965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNA2 | ENST00000316361.10 | c.1185G>C | p.Ala395Ala | synonymous_variant | 3/3 | 2 | NM_004974.4 | ENSP00000314520.4 |
Frequencies
GnomAD3 genomes AF: 0.0438 AC: 6663AN: 152034Hom.: 191 Cov.: 32
GnomAD3 exomes AF: 0.0529 AC: 13302AN: 251392Hom.: 533 AF XY: 0.0561 AC XY: 7617AN XY: 135872
GnomAD4 exome AF: 0.0514 AC: 75116AN: 1461756Hom.: 2340 Cov.: 34 AF XY: 0.0529 AC XY: 38504AN XY: 727192
GnomAD4 genome AF: 0.0439 AC: 6672AN: 152152Hom.: 192 Cov.: 32 AF XY: 0.0461 AC XY: 3427AN XY: 74378
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 22, 2017 | - - |
Developmental and epileptic encephalopathy, 32 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 24, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at